Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13) Peptide
TNFSF13
Reactivity: Human
Host: Synthetic
BP, BI
Catalog No. ABIN5686922
Quick Overview for Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13) Peptide (ABIN5686922)
Target
TNFSF13
(Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), BioImaging (BI)
-
-
Characteristics
- APRIL peptide corresponds to 13 amino acids of APRIL.
-
-
-
-
Application Notes
- APRIL Peptide is used for blocking the activity of APRIL antibody . The APRIL antibody ships at 0.5 mg/mL and the APRIL Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- APRIL peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
-
You are here:
